Regulatory authority and clinical acceptability: Physicians' responses to regulatory drug safety warnings.
Alice L BhasaleAmeet SarpatwariWendy LipworthMathias MøllebaekEliza J McEwinNileesa GautamAdrian Santiago OrtizBarbara J MintzesPublished in: British journal of clinical pharmacology (2021)
Drug safety warnings may not be optimally received or used. Regulators should consider strategies that increase trust, clinical relevance and accessibility, and address physicians' needs in communicating risk to patients.